-20℃ 3 years powder
-80℃ 2 years in solvent
LDH-IN-1 is a pyrazole-based human lactate dehydrogenase (LDH) inhibitor(IC50s of 32 and 27 nM for LDHA and LDHB, respectively).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | 277.00 | |
5 mg | In stock | 565.00 | |
10 mg | In stock | 876.00 | |
25 mg | In stock | 1807.00 | |
50 mg | In stock | 2841.00 | |
100 mg | In stock | 4082.00 | |
1 mL * 10 mM (in DMSO) | In stock | 780.00 |
Description | LDH-IN-1 is a pyrazole-based human lactate dehydrogenase (LDH) inhibitor(IC50s of 32 and 27 nM for LDHA and LDHB, respectively). |
Targets&IC50 | LDHA :ic50 32 nM, LDHB :ic50 27 nM, |
In vitro | LDH-IN-1 exhibit low nM inhibition of both LDHA and LDHB, submicromolar inhibition of lactate production, and inhibition of glycolysis in MiaPaCa2 pancreatic cancer and A673 sarcoma cells. |
Molecular Weight | 570.68 |
Formula | C30H26N4O4S2 |
CAS No. | 1964515-43-2 |
-20℃ 3 years powder
-80℃ 2 years in solvent
( < 1 mg/ml refers to the product slightly soluble or insoluble )
Safe and effective drug dosing is necessary, regardless of its purpose of administration. Learn More
bottom
Answers to questions you may have can be found in the Inhibitor Handling Instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.